Market Closed -
Nyse
21:00:02 21/06/2024 BST
5-day change
1st Jan Change
20.25
USD
+1.20%
+3.69%
-12.53%
Presentation Operator MessageOperator (Operator)Good evening, ladies and gentlemen, and welcom...
This article is reserved for subscribers
Signed up already?
Log In Not subscribed yet?
Subscribe
Truist Securities Adjusts Price Target on Phreesia to $29 From $35, Maintains Buy Rating
06-03
MT
Transcript : Phreesia, Inc., Q1 2025 Earnings Call, May 30, 2024
05-30
Phreesia Fiscal Q1 Net Loss Narrows, Revenue Increases; Lowers Fiscal 2025 Revenue Outlook
05-30
MT
Earnings Flash (PHR) PHREESIA Reports Q1 Revenue $101.2M
05-30
MT
Phreesia, Inc. Reports Earnings Results for the First Quarter Ended April 30, 2024
05-30
CI
Phreesia, Inc. Updates Earnings Guidance for the Year 2025
05-30
CI
Phreesia Insider Sold Shares Worth $610,684, According to a Recent SEC Filing
03-25
MT
JMP Securities Raises Price Target on Phreesia to $30 From $28, Maintains Market Outperform Rating
03-21
MT
Phreesia Names Jack Callahan as Chief Technology Officer
03-19
MT
Phreesia Appoints Jack Callahan as Chief Technology Officer
03-19
CI
Baird Adjusts Price Target on Phreesia to $31 From $30, Maintains Outperform Rating
03-18
MT
Raymond James Raises Phreesia's Price Target to $30 From $25, Maintains Outperform Rating
03-15
MT
Canaccord Genuity Adjusts Price Target on Phreesia to $37 From $36, Maintains Buy Rating
03-15
MT
RBC Raises Price Target on Phreesia to $23 From $17, Cites 'Encouraging Progress Toward Profitability,' Keeps Sector Perform Rating
03-15
MT
Transcript : Phreesia, Inc., Q4 2024 Earnings Call, Mar 14, 2024
03-14
Phreesia Fiscal Q4 Net Loss Narrows, Revenue Increases; FY 2025 Revenue Outlook Maintained; Shares Rise After Hours
03-14
MT
Phreesia Guides For FY 2025 Revenue of $424-$434 Million, vs CIQ Analyst Consensus of $428 Million
03-14
MT
Earnings Flash (PHR) PHREESIA Posts Q4 Revenue $95M, vs. Street Est of $93.5M
03-14
MT
Phreesia, Inc. Reports Earnings Results for the Fourth Quarter Ended January 31, 2024
03-14
CI
Phreesia, Inc. Reports Earnings Results for the Full Year Ended January 31, 2024
03-14
CI
Truist Securities Initiates Phreesia at Buy Rating With $35 Price Target
02-26
MT
Phreesia Insider Sold Shares Worth $1,630,138, According to a Recent SEC Filing
01-18
MT
Phreesia Insider Sold Shares Worth $1,046,093, According to a Recent SEC Filing
01-18
MT
Phreesia Insider Sold Shares Worth $796,441, According to a Recent SEC Filing
01-18
MT
Phreesia Insider Sold Shares Worth $458,552, According to a Recent SEC Filing
01-18
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. The Company also provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
More about the company
Last Close Price
20.25
USD
Average target price
29.06
USD
Spread / Average Target
+43.52%
Consensus
1st Jan change
Capi.
-12.53% 1.16B +19.61% 3,343B +17.60% 92.78B +16.90% 87.29B +38.85% 53.09B -21.37% 48.57B +35.78% 47.79B +86.22% 43.32B -31.70% 42.29B -1.70% 27.69B
Other Software
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1